Search Results 201-210 of 13386 for Birth Control Palette

1. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

   A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With ...

2. A Study Of Alcohol Use In Alcohol-associated Liver Disease - Mayo Clinic

   ... birth control during the study and for at least 30 days after the last dose of the study medication. Examples of acceptable birth control methods include ...

3. Effect of Secretin on Gastric Accommodation, Emptying and Post-nutrient Challenge Symptoms in Functional Dyspepsia and Healthy Subjects - Mayo Clinic

   ... birth control must be used throughout the study. Female subjects unable to ... birth control have not been conducted) are permissible. History of ...

4. Adolescents with Brachial Plexus Birth Palsy (BPBP) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Mayo Clinic

   Research & Education at Mayo Clinic. Research. Research at Mayo Clinic · Research Faculty · Laboratories · Core Facilities · Centers & Programs.

6. A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial

   Participation eligibility · Male condoms with spermicide · Hormonal methods of contraception including combined oral contraceptive pills, vaginal ring, ...

7. Subcortical Arousal In Perceptual Awareness - Mayo Clinic

   * a female subject must have a negative pregnancy test and if sexually active, must be using a reliable form of birth control for the duration of the trial ...

8. A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome - Mayo Clinic

   ... contraception (barrier contraceptives, diaphragm, injections, intrauterine device, surgical sterilization, or abstinence); Recent or current use (within 30 ...

9. Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Male patients who agree to practice effective barrier contraception through 6 months after the last dose of alisertib or agree to abstain from heterosexual ...

10. Pediatrics Clinical Trials - Medical Professionals

    ... birth because the infant is not suspected to have LQTS before birth. ... control; and to correlate outcomes using ... Also, to improve disease control by ...